Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 23, 2020

SELL
$72.34 - $84.0 $575,175 - $667,884
-7,951 Closed
0 $0
Q1 2020

Apr 21, 2020

SELL
$62.63 - $80.22 $1.03 Million - $1.32 Million
-16,506 Reduced 67.49%
7,951 $594,000
Q4 2019

Jan 17, 2020

SELL
$61.62 - $67.78 $231,506 - $254,649
-3,757 Reduced 13.32%
24,457 $1.59 Million
Q3 2019

Oct 21, 2019

BUY
$62.51 - $69.0 $1,250 - $1,380
20 Added 0.07%
28,214 $1.79 Million
Q2 2019

Jul 18, 2019

SELL
$61.87 - $69.38 $12,374 - $13,876
-200 Reduced 0.7%
28,194 $1.91 Million
Q1 2019

Apr 04, 2019

SELL
$62.53 - $70.05 $87,854 - $98,420
-1,405 Reduced 4.71%
28,394 $0
Q4 2018

Jan 23, 2019

SELL
$60.54 - $79.0 $361,121 - $471,235
-5,965 Reduced 16.68%
29,799 $1.86 Million
Q3 2018

Oct 04, 2018

BUY
$71.28 - $78.92 $25,874 - $28,647
363 Added 1.03%
35,764 $2.76 Million
Q2 2018

Aug 01, 2018

SELL
$64.88 - $75.68 $8,888 - $10,368
-137 Reduced 0.39%
35,401 $2.51 Million
Q1 2018

May 01, 2018

SELL
$72.84 - $88.8 $73,422 - $89,510
-1,008 Reduced 2.76%
35,538 $2.68 Million
Q4 2017

Jan 31, 2018

SELL
$71.15 - $83.52 $650,097 - $763,122
-9,137 Reduced 20.0%
36,546 $2.62 Million
Q3 2017

Oct 27, 2017

BUY
$72.11 - $85.47 $3.29 Million - $3.9 Million
45,683
45,683 $3.7 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Btr Capital Management Inc Portfolio

Follow Btr Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.